A phase II study evaluating the utility of letrozole in the treatment of recurrent, estrogen receptor (ER) positive, epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer,
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2006
At a glance
- Drugs Letrozole (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 Feb 2006 New trial record.